Mechanistically, PGE2 released from COX2-expressing tumor cells impairs the interaction of conventional dendritic cells (cDC1) with CD8+ T cells leading to decreased antigen presentation and recruitment of CD8+ T cells to the TME (25, 26). This evidence concerns the gene CD8A and neoplasm.